Received: from malur.postgresql.org ([217.196.149.56]) by arkaria.postgresql.org with esmtps (TLS1.3:ECDHE_RSA_AES_256_GCM_SHA384:256) (Exim 4.92) (envelope-from ) id 1lEwVm-0001Eu-Rp for psycopg@arkaria.postgresql.org; Wed, 24 Feb 2021 15:55:38 +0000 Received: from localhost ([127.0.0.1] helo=malur.postgresql.org) by malur.postgresql.org with esmtp (Exim 4.92) (envelope-from ) id 1lEwVl-0003HR-QK for psycopg@arkaria.postgresql.org; Wed, 24 Feb 2021 15:55:37 +0000 Received: from makus.postgresql.org ([2001:4800:3e1:1::229]) by malur.postgresql.org with esmtps (TLS1.3:ECDHE_RSA_AES_256_GCM_SHA384:256) (Exim 4.92) (envelope-from ) id 1lEw2A-0004eH-DM for psycopg@lists.postgresql.org; Wed, 24 Feb 2021 15:25:02 +0000 Received: from mail-wells.osfhealthcare.org ([204.238.189.50]) by makus.postgresql.org with esmtps (TLS1.2:ECDHE_RSA_AES_256_GCM_SHA384:256) (Exim 4.92) (envelope-from ) id 1lEw27-0007lx-6f for psycopg@postgresql.org; Wed, 24 Feb 2021 15:25:00 +0000 IronPort-PHdr: =?us-ascii?q?9a23=3A14p9mRXniRQYtaVP/l0mBNj/Sn7V8LGtZVwlr6E/?= =?us-ascii?q?grcLSJyIuqrYZRWOvqdThVPEFb/W9+hDw7KP9fy5CCpQvt3Z6jgrS99lb1c9k8?= =?us-ascii?q?IYnggtUoauKHbQC7rUVRE8B9lIT1R//nu2YgB/Ecf6YEDO8DXptWZBUhrwOhBo?= =?us-ascii?q?KevrB4Xck9q41/yo+53Ufg5EmCexbal9IRmrqQjdrMobjIltJqot1BfCv2dFdf?= =?us-ascii?q?lRyW50P1yYggzy5t23/J5t8iRQv+wu+stdWqjkfKo2UKJVAi0+P286+MPkux/D?= =?us-ascii?q?TRCS5nQHSWUZjgBIAwne4x7kWJr6rzb3ufB82CmeOs32UKw0VDG/5KplVBPklC?= =?us-ascii?q?EKPCM//WrKiMJ/kbhbrQqhqRJh3oDUfI+bOvl/fqzBctwXXnBOUtpTVyFbHo+w?= =?us-ascii?q?c5UDAuwcNuhYtYn9oF4OoAOwCQeuGePvzCNIimfr1qAnyeQhEBvJ3Ao9FN8Qqn?= =?us-ascii?q?jYosj+OaAPXOCvzanH1zPDY+lI1Dvn6obIbxYhoe2XULJ3asrRx0kvGB3fgVWU?= =?us-ascii?q?tYzlPy+a2f4Xs2eF9eZgUvivi2E+pgx3vzOgydsihJPTiYIJ1lDL6z95wIAtKN?= =?us-ascii?q?O3VEJ3fcCoHptMuyybM4Z7Xt8uTm9ntig11rELt5+2cTUXxZkoyRDTduGLfpaW?= =?us-ascii?q?7h/gWuucIzl2inJkdb+/hxi/91WrxOP7VsmxyllKryxFn8HRuXAPzRPT7MeHSv?= =?us-ascii?q?xl/ke73jaP1R7c5f1YIUwuiaXbLJshzqY3lpoIv0TDHjH5l1/yjK+KdkUr5vKn?= =?us-ascii?q?6/75bbn8oZ+cLYB0hhnwMqs0hsOwH/83Mg8JX2iY4+izyLrj/UjhTLVWgPw2k7?= =?us-ascii?q?XZsIzEKsQBvKK2HwhV0oM75xe/CDemzcgYnWQcI11bYh6Ik4/pO1TILfvlDvm/?= =?us-ascii?q?m0yhnCp3y/zcI7HsDZrAImLenLrjZ7px9kxRxQQrwdxC+55YEKwNLfzuVkPrtN?= =?us-ascii?q?HUEgU1PxK3zuvhFd5zzJkRWXiVDa+cKK7StFiI6f8xLOSUf48VvSr9K+Ai5/7z?= =?us-ascii?q?kX81gV8dcret3ZsQcH24BvFmLFmAbXXwgtcBEH4Gvg8xTeD3llGOSz9TZ3CuX6?= =?us-ascii?q?Im/D47DpypDZvZSoCqm7yB0iG7EYNKZmxcDVCMC3joe52FW/cKdi2SPtdsniEY?= =?us-ascii?q?WbS7VoMs2h6juBXnx7dlNObY5y8VuJz72Nhw/eLTlBUy9TJuD8Sa1mGAV3x5nn?= =?us-ascii?q?kJRzAs2qBzu1Jwxk2B36hlhfxYCcde5/RSUgc0NZ7T0fZ1C9TuWgLBYtiGUkym?= =?us-ascii?q?Tcu8DTE2VNIxzMcCY1xhFNW6khDDwy2qDqcbl7yMC5w56aPc337wJ8Zh1nnKzq?= =?us-ascii?q?4hj0MpQsFXL22pmrZ/9xTPB47Oi0iZj72qdKQA0y7K7GeDwnGDvFlfUA5rTaXF?= =?us-ascii?q?UmofaVXNrdTg4kPOVbiuCa4oMlgJ9cnXYOREbdLBjFNHWPulP87RLCj5z2m3Cj?= =?us-ascii?q?6JwLKQYMztYWpLmG2XR1AfggsU5XmuLQ8lGii7rnnHCHppD12gKQu46fJvo3Sj?= =?us-ascii?q?QWcsyBqWYFdszKOxvBkPiqrPZekU2+dOmDont3E8Nky81tSeIJzK715LZqRVZ5?= =?us-ascii?q?UWpnda037xsBdzPpGpK7xijVcEfkJwpUy4hEY/MZlJjcV/9CBi9wF1M6/NiF4?= =?us-ascii?q?=3D?= X-IronPort-Anti-Spam-Filtered: true X-IronPort-Anti-Spam-Result: =?us-ascii?q?A2FIDAD8bjZg/60RkApfAxwBAQEBAQEHA?= =?us-ascii?q?QESAQEEBAEBQIFPAoEhgWkVgUEKlCuBaYNKjiGCRW6GcxYmCwEDAQEBCgEoDAQ?= =?us-ascii?q?BAQMBgVSEbyc5BQ0CEAEBAQUBAQEBAQYEAQEChk4NgjgiGAFiPRkBAQEBAQEBA?= =?us-ascii?q?QEnAgEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQUCDTcLEDg?= =?us-ascii?q?LVxxCAYEmAQQBGgEWgk2BfoEXr0eBNIQ/AYEYhH6BOAGGe4ZGgSZeQYERhioLA?= =?us-ascii?q?oFNWYUuBIJAgUABgRsUEyUcjhGNdp4ODAcDCIIJa4dhgV2QV4F8K5NNj32UTIs?= =?us-ascii?q?3llwCAgICCQIWgWyBen2DLAlHFwINkg6FFIVFczgCBgoBAQMJiwQyXQEB?= X-IPAS-Result: =?us-ascii?q?A2FIDAD8bjZg/60RkApfAxwBAQEBAQEHAQESAQEEBAEBQIF?= =?us-ascii?q?PAoEhgWkVgUEKlCuBaYNKjiGCRW6GcxYmCwEDAQEBCgEoDAQBAQMBgVSEbyc5B?= =?us-ascii?q?Q0CEAEBAQUBAQEBAQYEAQEChk4NgjgiGAFiPRkBAQEBAQEBAQEnAgEBAQEBAQE?= =?us-ascii?q?BAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQUCDTcLEDgLVxxCAYEmAQQBG?= =?us-ascii?q?gEWgk2BfoEXr0eBNIQ/AYEYhH6BOAGGe4ZGgSZeQYERhioLAoFNWYUuBIJAgUA?= =?us-ascii?q?BgRsUEyUcjhGNdp4ODAcDCIIJa4dhgV2QV4F8K5NNj32UTIs3llwCAgICCQIWg?= =?us-ascii?q?WyBen2DLAlHFwINkg6FFIVFczgCBgoBAQMJiwQyXQEB?= X-IronPort-AV: E=Sophos;i="5.81,203,1610431200"; d="scan'208,217";a="74293885" Received: from pmc-chi-mx12.intranet.osfnet.org ([10.144.17.173]) by mail-wells.osfhealthcare.org with ESMTP/TLS/AES256-GCM-SHA384; 24 Feb 2021 09:24:57 -0600 Received: from pmc-pia-mx14.intranet.osfnet.org (10.131.50.17) by pmc-chi-mx12.intranet.osfnet.org (10.144.17.173) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_128_CBC_SHA256_P256) id 15.1.2044.4; Wed, 24 Feb 2021 09:24:57 -0600 Received: from pmc-pia-mx14.intranet.osfnet.org ([fe80::e062:4ce6:9159:231b]) by pmc-pia-mx14.intranet.osfnet.org ([fe80::e062:4ce6:9159:231b%12]) with mapi id 15.01.2044.006; Wed, 24 Feb 2021 09:24:57 -0600 From: "Hunt, Brian C." To: "'fog@initd.org'" , "'psycopg@postgresql.org'" Subject: License LPGL and commercialization Thread-Topic: License LPGL and commercialization Thread-Index: AdcKwRhe/Usz6H1GR/CCFEcS14HseA== Date: Wed, 24 Feb 2021 15:24:56 +0000 Message-ID: Accept-Language: en-US Content-Language: en-US X-MS-Has-Attach: X-MS-TNEF-Correlator: x-originating-ip: [10.131.50.28] Content-Type: multipart/alternative; boundary="_000_ce175cbd83bc4258b1f2996fcccff75aosfhealthcareorg_" MIME-Version: 1.0 X-CrossPremisesHeadersFilteredBySendConnector: pmc-chi-mx12.intranet.osfnet.org X-OrganizationHeadersPreserved: pmc-chi-mx12.intranet.osfnet.org List-Id: List-Help: List-Subscribe: List-Post: List-Owner: List-Archive: Precedence: bulk --_000_ce175cbd83bc4258b1f2996fcccff75aosfhealthcareorg_ Content-Type: text/plain; charset="us-ascii" MIME-Version: 1.0 Content-Transfer-Encoding: quoted-printable I have recently been told by outside council (lawyers) that our organizatio= n is unable to use LGPL licensed packages in software we plan to sell. We have already built a web app using Python + Django. Ticket: #461 (Support use of pypgsql instead of psycopg) - Django (djangoproject.co= m) Seems to suggest the purpose of the LGPL license is not to prevent the inte= nded use we have in mind (selling the web app to be hosted locally at other= organizations). Instead it is to prevent other from building off the drive= rs and then selling those drivers. Is that the case? Is our intended purpose within the license constraints ou= tlined? Can we receive written confirmation that our intended use won't com= e back to hurt us and we have permission? Or can we not use your package in= this way? We will be compliant with whatever outcome is required. If we ne= ed to move away from Django (psycopg2) then we can do that if needed. Brian Hunt Data Scientist I, Advanced Analytics OSF HealthCare System 1306 N. Berkeley Ave. | Peoria, IL | 61603 p 309-308-9657 | f 309-308-0530 www.osfhealthcare.org Facebook | Twitter | YouTube "Serving with the Greatest Care and Love" =3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D The information in this message is confidential and may be legally privileg= ed. Access to this message by anyone other than the addressee is not author= ized. If you are not the intended recipient, or an agent of the intended re= cipient, any disclosure, copying, or distribution of the message or any act= ion or omission taken by you in reliance on it, is prohibited and may be un= lawful. If you have received this message in error, please contact the send= er immediately and permanently delete the original e-mail, attachment(s), a= nd any copies. =3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D --_000_ce175cbd83bc4258b1f2996fcccff75aosfhealthcareorg_ Content-Type: text/html; charset="us-ascii" MIME-Version: 1.0 Content-Transfer-Encoding: quoted-printable

I have recently been told by outside council (lawyer= s) that our organization is unable to use LGPL licensed packages in softwar= e we plan to sell.

We have already built a web app using Python + D= jango.

 

Ticket:

#461 (Support use of pypgsql instead of psycopg) – Django (djangopr= oject.com)

Seems to suggest the purpose of the LGPL license is = not to prevent the intended use we have in mind (selling the web app to be = hosted locally at other organizations). Instead it is to prevent other from= building off the drivers and then selling those drivers.

 

Is that the case? Is our intended purpose within the= license constraints outlined? Can we receive written confirmation that our= intended use won’t come back to hurt us and we have permission? Or c= an we not use your package in this way? We will be compliant with whatever outcome is required. If we need to move= away from Django (psycopg2) then we can do that if needed.

 

 

Brian Hunt

Data Scientist I, Advanced Analytics<= /o:p>

OSF HealthCare System

1306 N. Berkeley Ave. | Peoria, IL | 61603=

p 309-308-9657 | f 309-308-0530=

www.osfhealthcare.org
Facebo= ok | Twitter= | YouTube=

"Serving with the Greatest Care an= d Love"

 

=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D
The information in this message is confidential and may be legally privileg= ed. Access to this message by anyone other than the addressee is not author= ized. If you are not the intended recipient, or an agent of the intended re= cipient, any disclosure, copying, or distribution of the message or any act= ion or omission taken by you in reliance on it, is prohibited and may be un= lawful. If you have received this message in error, please contact the send= er immediately and permanently delete the original e-mail, attachment(s), a= nd any copies.
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D

--_000_ce175cbd83bc4258b1f2996fcccff75aosfhealthcareorg_--